Apparent cortisone reductase deficiency: A unique form of hypercortisolism

被引:69
作者
Phillipov, G
Palermo, M
Shackleton, CHL
机构
[1] CHILDRENS HOSP, OAKLAND RES INST, OAKLAND, CA 94609 USA
[2] QUEEN ELIZABETH HOSP, ENDOCRINE & DIABET SERV, WOODVILLE, SA 5011, AUSTRALIA
[3] UNIV SASSARI, DEPT HEMATOL & ENDOCRINOL, I-07100 SASSARI, SARDINIA, ITALY
关键词
D O I
10.1210/jc.81.11.3855
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe two female siblings who had production of cortisol (F; as determined from excretion of urinary metabolites) high enough to give rise to Cushing's disease, but who had no clinical indications of the condition. The teenage patients were hirsute as a result of adrenal hyperandrogenism. A notable feature of the condition was the elevated excretion of corticosteroid metabolites with 11-carbonyl groups and very low excretion of 11 beta-hydroxylated steroids. We termed this disorder apparent cortisone (E) reductase disorder. The steroid metabolite phenotype appeared to be the opposite of that seen in the apparent mineralocorticoid excess syndrome, in which the excretion of 11-keto compounds is attenuated. As an example, the tetrahydrocortisol plus 5 alpha-tetrahydrocortisol/tetrahydrocortisone ratio was about 0.04 compared to normal values of about 1.0 and apparent mineralocorticoid excess syndrome values of 5.0-50.0. Paradoxically, among the F metabolites that had not undergone A-ring reduction, 11 beta-hydroxylated steroids dominated over Il-carbonyl compounds. The F/E ratio was about 1.8 compared to an average normal value of 0.54. Neither the father nor the mother of the patient had abnormal F metabolite/E metabolite ratios, although the father did excrete highly elevated free E and F, possibly an unrelated condition. A conclusion was not reached regarding the basis of the disorder. We considered that the most likely causes were 1) defective hepatic 11 beta-hydroxysteroid dehydrogenase-1, 2) failure to develop the adult form of F metabolism, or 3) excessive activity of A ring reduction enzymes acting on E.
引用
收藏
页码:3855 / 3860
页数:6
相关论文
共 35 条
[1]  
AGARWAL AK, 1994, J BIOL CHEM, V269, P25959
[2]   EXPRESSION OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE USING RECOMBINANT VACCINIA VIRUS [J].
AGARWAL, AK ;
TUSIELUNA, MT ;
MONDER, C ;
WHITE, PC .
MOLECULAR ENDOCRINOLOGY, 1990, 4 (12) :1827-1832
[3]   CLONING AND TISSUE DISTRIBUTION OF THE HUMAN 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2 ENZYME [J].
ALBISTON, AL ;
OBEYESEKERE, VR ;
SMITH, RE ;
KROZOWSKI, ZS .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1994, 105 (02) :R11-R17
[4]   METABOLIC CLEARANCE RATES AND INTERCONVERSION OF CORTISOL AND CORTISONE [J].
DAZORD, A ;
SAEZ, J ;
BERTRAND, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1972, 35 (01) :24-+
[5]   LOCALIZATION OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TISSUE SPECIFIC PROTECTOR OF THE MINERALOCORTICOID RECEPTOR [J].
EDWARDS, CRW ;
BURT, D ;
MCINTYRE, MA ;
DEKLOET, ER ;
STEWART, PM ;
BRETT, L ;
SUTANTO, WS ;
MONDER, C .
LANCET, 1988, 2 (8618) :986-989
[6]  
EISENSCHMID B, 1987, J CLIN CHEM CLIN BIO, V25, P345
[7]   RENAL CAPTURE AND OXIDATION OF CORTISOL IN MAN [J].
HELLMAN, L ;
NAKADA, F ;
ZUMOFF, B ;
FUKUSHIMA, D ;
BRADLOW, HL ;
GALLAGHER, TF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1971, 33 (01) :52-+
[8]   METABOLISM OF CORTISOL BY HUMAN EXTRA-HEPATIC TISSUES [J].
JENKINS, JS .
JOURNAL OF ENDOCRINOLOGY, 1966, 34 (01) :51-&
[9]   PURIFICATION AND CHARACTERIZATION OF THE CORTICOSTEROID 11 BETA-DEHYDROGENASE COMPONENT OF THE RAT-LIVER 11 BETA-HYDROXYSTEROID DEHYDROGENASE COMPLEX [J].
LAKSHMI, V ;
MONDER, C .
ENDOCRINOLOGY, 1988, 123 (05) :2390-2398
[10]   HUMAN HYPERTENSION CAUSED BY MUTATIONS IN THE KIDNEY ISOZYME OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE [J].
MUNE, T ;
ROGERSON, FM ;
NIKKILA, H ;
AGARWAL, AK ;
WHITE, PC .
NATURE GENETICS, 1995, 10 (04) :394-399